Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Gastric Ulcers Market Through 2034?
In recent times, the market size of gastric ulcers has expanded significantly. The market is expected to escalate from $4.29 billion in 2024 to $4.53 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include the increasing incidence of helicobacter pylori infections, the heightened usage of nonsteroidal anti-inflammatory drugs (NSAIDs), the global rise in the aging population, the proliferation of awareness programs to prevent gastric ulcers, and the growing prevalence of stress-related disorders.
Significant expansion is anticipated in the gastric ulcers market in the coming years, with an expected surge to$5.55 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This expansion during the predicted period can be credited to advancements in diagnostic techniques, the prevalence of unhealthy dietary patterns, progression in treatment methods like proton pump inhibitors (PPIs), an increase in the aging population leading to a higher disease load, and the growth of healthcare infrastructure in upcoming markets. Foreseen trends for the forecasted period incorporate a shift towards combined therapies for improved effectiveness, a growing favor for minimally invasive treatment procedures, the function of digital health remedies in disease control, an increased need for over-the-counter (OTC) ulcer medications, and the broadening of individualized medicine strategies in ulcer treatment.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp
What Are the Core Market Drivers Propelling Growth in the Gastric Ulcers Industry?
The growth of the gastric ulcers market is set to be bolstered by a rising elderly population. This group, typically those aged 65 and over, encounter unique health challenges associated with the aging process. Improvements in healthcare, coupled with dropping birth rates globally, have contributed to an added number of individuals within this demographic. Gastric ulcers are widespread among this group due to increased NSAIDs usage and reduced mucosal protection, subsequently leading to a heightened risk of complications. As an example, projections from the Population Reference Bureau (PRB), a non-profit organization based in the U.S., suggest that by January 2024, the number of Americans enjoying their golden years is set to surge from 58 million in 2022 to an impressive 82 million by 2050, marking an increase of 47%. Furthermore, the ratio of this age group to the total population is projected to climb from 17% to 23%. This shift underscores a marked aging trend among the American populace, thereby emphasizing the growing need to cater to senior citizens across varying sectors. Consequently, the upward trend in the elderly population is fuelling the expansion of the gastric ulcers market.
How Is the Gastric Ulcers Market Segmented?
The gastric ulcersmarket covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes
2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users
Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole
2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine
3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate
4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline
5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp
Which Regions Are Driving the Next Phase of the Gastric Ulcers Market Growth?
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Gastric Ulcers Industry?
Key players in the gastric ulcer market are concentrating on the creation of innovative offerings, like fresh drug formulations, in order to improve treatment effectiveness and mitigate side effects. Novel formulation drugs encompass medicines that feature pioneering blends of active components, conveyance mechanisms, or dosage forms to augment efficacy, safety and patient adherence. For example, Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical preparation enterprise based in India, rolled out Rabeprazole + Levosulpiride SR Capsules in June 2024. This product is intended to offer superior relief for ailments like gastro-oesophageal reflux disease (GERD) and other disorders of the gastrointestinal tract (GIT). These products mix a proton pump inhibitor and a prokinetic agent, efficiently handling gastrointestinal ailments such as GERD and gastric ulcers. This concoction not only decreases gastric acid secretion, but also promotes gastric mobility, offering thorough relief from symptoms like heartburn and indigestion.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report
How Is the Gastric Ulcers Market Defined and What Are Its Core Parameters?
Gastric ulcers, also known as peptic ulcers, are open sores on the stomach’s inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model